On September 12, 2019 VAXIMM AG, a Swiss/German biotech company focused on developing oral T-cell immunotherapies, reported that the Company will participate in several events around the globe in the coming months (Press release, Vaximm, SEP 12, 2019, View Source [SID1234539461]). Company representatives will be available for networking and one-on-one meetings at the following conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
3rd Annual China Cross-Border Healthcare Investment Summit
September 17-20, 2019
Hangzhou & Chengdu, China
Dr. Heinz Lubenau, Chief Operating Officer & Co-Founder of VAXIMM, will give corporate presentations and participate in one-on-one meetings with top-tier Chinese healthcare investors. The program can be found here.
5th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (CIMT) (Free CIMT Whitepaper)
September 25-28, 2019
Paris, France
VAXIMM representatives will be available for one-on-one meetings during the conference. To schedule a meeting, please contact [email protected].
25th Annual International Partnering Conference BIO-Europe
November 11-13, 2019
Hamburg, Germany
VAXIMM plans to give a corporate presentation and host one-on-one meetings at this event. To request a meeting, please sign up through the event’s partneringONE meeting system.
Jefferies 2019 London Healthcare Conference
November 20-21, 2019
London, UK
Management will be available for one-on-one meetings.
4th Annual NeoAg Summit
November 20-22, 2019
Boston, USA
Dr. Lubenau will give a presentation entitled, "Oral T-Cell Therapies for Personalized Neoantigen-Targeting Treatment," during the session, "Clinical & Translational – Interrogating the Best Manufacturing Platforms to Reduce Needle to Needle Time," on November 22 at 11 AM ET. The program can be found here.